PRODUCTS
CONTACT US
Hangzhou Biotest Biotech Co., Ltd
Tel: International Regions
+86-571-89058016
North America/Latin America
+86-571-89058051
China
+86-571-89058000
Fax: +86-571-88633388
E-mail:info.support@biotests.com.cn
ADD: 17# Futai Road,Zhongtai Street, Yuhang District,
Hangzhou, China
Postal Code: 311121
COVID-19+Flu A&B+RSV Antigen Combo Rapid Test
A rapid test for the qualitative detection of SARS-CoV-2, Flu A&B, RSV Antigen in Nasopharyngeal swab For professional in vitro diagnostic use only.
- Description
- Specifications
-
【INTENDED USE】
The COVID-19+Flu A&B+RSV Antigen Combo Rapid Test Cassette (Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of COVID-19, Influenza A&B, RSV Antigen in Nasopharyngeal swab. It is intended to aid in the rapid differential diagnosis of COVID-19, Influenza A&B, RSV infections.
【SUMMARY】
The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
Influenza (commonly known as ‘flu’) is a highly contagious, acute viral infection of the respiratory tract. It is a communicable disease easily transmitted through the coughing and sneezing of aerosolized droplets containing live virus. Influenza outbreaks occur each year during the fall and winter months. Type A viruses are typically more prevalent than type B viruses and are associated with most serious influenza epidemics, while type B infections are usually milder.
Human respiratory syncytial virus (HRSV) is a syncytial virus that causes respiratory tract infections. It is a major cause of lower respiratory tract infections and hospital visits during infancy and childhood. A prophylactic medication, palivizumab, can be employed to prevent HRSV in preterm (under 35 weeks gestation) infants, infants with certain congenital heart defects (CHD) or bronchopulmonary dysplasia (BPD), and infants with congenital malformations of the airway. Treatment is limited to supportive care (e.g. C-PAP), including oxygen therapy. In temperate climates there is an annual epidemic during the winter months. In tropical climates, infection is most common during the rainy season.
【DIRECTIONS FOR USE】
【Order Information】
Cat. No.
Product
Specimen
Format
Pack ICFR-MC84
COVID-19+Flu A&B+RSV Antigen Combo Rapid Test
Nasopharyngeal swab
Cassette
25T
Copyright©Hangzhou Biotest Biotech Co., LTD . All rights reserved. ICP:11051548-1 Powered by clouddream